Haemonetics (HAE) Tops Q2 EPS by 7c, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Haemonetics (HAE) PT Raised to $59 at Jefferies; Reiterates Buy
November 8, 2017 9:08 AM ESTJefferies raised its price target on Haemonetics (NYSE: HAE) to $59.00 (from $48.00) while maintaining a Buy rating. The upgrade cycle for NexSys appears underway with several customers launching trials in September while full market release mid-next year assumes new contracts are in place.
The... More
Haemonetics (HAE) PT Raised $50 at Craig-Hallum
November 8, 2017 8:02 AM ESTCraig-Hallum raised its price target on Hold-rated Haemonetics (NYSE: HAE) to $50.00 (from $40.00).
Analyst Matthew Hewitt said the turnaround appears on track and cash flow is improving.
For an analyst ratings summary and ratings history on Haemonetics... More
